5.3.1.8 6-phosphofructokinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=139680&form=6&db=m [Exercise-induced muscular weakness, myalgia and contractures. I. A clinical review] causal interaction,unassigned 3,0 5.3.1.8 6-phosphofructokinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=847445&form=6&db=m [Exercise-induced muscular weakness, myalgia and contractures. II. Casuistic contribution] causal interaction,unassigned 4,0 5.3.1.8 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34511962&form=6&db=m Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma. causal interaction,diagnostic usage,unassigned 4,4,0 5.3.1.8 Alcohol Withdrawal Delirium http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5573906&form=6&db=m Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens. unassigned - 5.3.1.8 Alcohol Withdrawal Delirium http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5805104&form=6&db=m [Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens] unassigned - 5.3.1.8 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13605990&form=6&db=m [Erythrocyte enzymes; activity of glycolytic enzymes of erythrocytes in anemia: phosphoglucomutase, phosphohexoisomerase, diphosphofructaldolase, lactic acid dehydrogenase.] ongoing research,unassigned 1,0 5.3.1.8 Biliary Tract Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5941685&form=6&db=m [Serum iron and copper levels and serum activity of phosphohexoisomerase and glutamic-pyruvic transaminase in patients with liver and biliary tract disease] diagnostic usage,ongoing research,unassigned 4,3,0 5.3.1.8 Blindness http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24421398&form=6&db=m Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. causal interaction,ongoing research,unassigned 3,1,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9525984&form=6&db=m Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. causal interaction,therapeutic application,unassigned 4,1,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9585601&form=6&db=m Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. causal interaction,unassigned 3,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9821433&form=6&db=m Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,3,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10484808&form=6&db=m Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. causal interaction,therapeutic application,unassigned 2,1,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10783607&form=6&db=m [Carbohydrate-deficient glycoprotein syndrome (CDGS) type Ib. A hereditary metabolic disease and its therapy] causal interaction,unassigned 2,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10980531&form=6&db=m Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). causal interaction,ongoing research,unassigned 3,2,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11567948&form=6&db=m Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose. causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12530817&form=6&db=m Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib. diagnostic usage,ongoing research,unassigned 3,1,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19101627&form=6&db=m The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. causal interaction,therapeutic application,unassigned 4,4,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19157945&form=6&db=m Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts. ongoing research,unassigned 1,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20523973&form=6&db=m Ontogeny of D-mannose transport and metabolism in rat small intestine. causal interaction,therapeutic application,unassigned 4,4,0 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22899857&form=6&db=m A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. unassigned - 5.3.1.8 Congenital Disorders of Glycosylation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26430078&form=6&db=m A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies. unassigned - 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10980531&form=6&db=m Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). causal interaction,ongoing research,unassigned 3,2,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11350186&form=6&db=m Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. causal interaction,unassigned 4,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12530817&form=6&db=m Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib. diagnostic usage,ongoing research,unassigned 3,1,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19101627&form=6&db=m The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. causal interaction,therapeutic application,unassigned 4,4,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19157945&form=6&db=m Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts. ongoing research,unassigned 1,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20523973&form=6&db=m Ontogeny of D-mannose transport and metabolism in rat small intestine. causal interaction,therapeutic application,unassigned 4,4,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21539312&form=6&db=m Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia. causal interaction,therapeutic application,unassigned 3,4,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22899857&form=6&db=m A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. unassigned - 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24407290&form=6&db=m The metabolic origins of mannose in glycoproteins. causal interaction,unassigned 4,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24421398&form=6&db=m Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. causal interaction,ongoing research,unassigned 3,1,0 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26430078&form=6&db=m A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies. unassigned - 5.3.1.8 Congenital, Hereditary, and Neonatal Diseases and Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29531722&form=6&db=m A novel homozygous mutation in the mannose phosphate isomerase gene causing congenital disorder of glycation and hyperinsulinemic hypoglycemia in an infant. causal interaction,unassigned 3,0 5.3.1.8 Coronary Artery Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32762555&form=6&db=m Molecular and Biochemical Parameters Related to Plasma Mannose Levels in Coronary Artery Disease Among Nondiabetic Patients. diagnostic usage,ongoing research,unassigned 4,3,0 5.3.1.8 Cystic Fibrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3036776&form=6&db=m Alginate biosynthetic enzymes in mucoid and nonmucoid Pseudomonas aeruginosa: overproduction of phosphomannose isomerase, phosphomannomutase, and GDP-mannose pyrophosphorylase by overexpression of the phosphomannose isomerase (pmi) gene. therapeutic application,unassigned 1,0 5.3.1.8 Cystic Fibrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18668237&form=6&db=m Functional analysis of the Burkholderia cenocepacia J2315 BceA(J) protein with phosphomannose isomerase and GDP-D: -mannose pyrophosphorylase activities. unassigned - 5.3.1.8 Diphtheria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=985662&form=6&db=m Assignment of hexosaminidase-B to chromosome 5, its segregation after diphtheria toxin selection, and the linkage of hexosaminidase-A, mannose phosphate isomerase, and pyruvate kinase (M2). unassigned - 5.3.1.8 Diphtheria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1024612&form=6&db=m Assignment of hexosaminidase-B to chromosome 5, its segregation after diphtheria toxin selection, and the linkage of hexosaminidase-A, mannose phosphate isomerase, and pyruvate kinase (M2). unassigned - 5.3.1.8 Ependymoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17340808&form=6&db=m [Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia] causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Fructose Intolerance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8910943&form=6&db=m Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. causal interaction,unassigned 4,0 5.3.1.8 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25314669&form=6&db=m Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity. unassigned - 5.3.1.8 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5939632&form=6&db=m [The diagnostic value of determining serum iron and copper levels and activity of phosphohexoisomerase and pyruvic-glutamic transaminase in viral hepatitis] diagnostic usage,unassigned 4,0 5.3.1.8 Hepatitis A http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14138463&form=6&db=m [MICRODETERMINATION OF PHOSPHOHEXOISOMERASE (GLUCOSEPHOSPHATE ISOMERASE) IN THE SERUM AND THE CLINICAL IMPORTANCE OF ITS DETERMINATION IN INFECTIOUS HEPATITIS.] diagnostic usage,unassigned 2,0 5.3.1.8 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761048&form=6&db=m History of safe exposure and bioinformatic assessment of phosphomannose-isomerase (PMI) for allergenic risk. causal interaction,unassigned 2,0 5.3.1.8 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10484808&form=6&db=m Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. causal interaction,therapeutic application,unassigned 2,1,0 5.3.1.8 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10586187&form=6&db=m Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. causal interaction,unassigned 4,0 5.3.1.8 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24421398&form=6&db=m Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. causal interaction,ongoing research,unassigned 3,1,0 5.3.1.8 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29531722&form=6&db=m A novel homozygous mutation in the mannose phosphate isomerase gene causing congenital disorder of glycation and hyperinsulinemic hypoglycemia in an infant. causal interaction,unassigned 3,0 5.3.1.8 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32905087&form=6&db=m Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia. causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Leishmaniasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2091345&form=6&db=m Biochemical characterization of Leishmania (Viannia) braziliensis and Leishmania (Viannia) peruviana by isoenzyme electrophoresis. ongoing research,unassigned 2,0 5.3.1.8 Leishmaniasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20720027&form=6&db=m Use of FTA cards for direct sampling of patients' lesions in the ecological study of cutaneous leishmaniasis. diagnostic usage,ongoing research,unassigned 1,3,0 5.3.1.8 Leishmaniasis, Cutaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33075058&form=6&db=m Nuclear and kinetoplast DNA analyses reveal genetically complex Leishmania strains with hybrid and mito-nuclear discordance in Peru. diagnostic usage,ongoing research,unassigned 3,2,0 5.3.1.8 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34533861&form=6&db=m Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 5.3.1.8 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31016744&form=6&db=m Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans. causal interaction,unassigned 2,0 5.3.1.8 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10586187&form=6&db=m Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. causal interaction,unassigned 4,0 5.3.1.8 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13234274&form=6&db=m [Studies on the serum enzymes in liver diseases; the activity of phosphohexoisomerase, aldolase and alkaline phosphatase.] diagnostic usage,ongoing research,unassigned 4,4,0 5.3.1.8 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24421398&form=6&db=m Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. causal interaction,ongoing research,unassigned 3,1,0 5.3.1.8 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31016744&form=6&db=m Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans. causal interaction,unassigned 2,0 5.3.1.8 Liver Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12069534&form=6&db=m Clinical approach to inherited metabolic disorders in neonates: an overview. causal interaction,unassigned 3,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3668496&form=6&db=m Mannose inhibition as a significant marker for differentiating among novobiocin-resistant staphylococci of relevance in clinical microbiology. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9525984&form=6&db=m Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. causal interaction,therapeutic application,unassigned 4,1,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9535779&form=6&db=m A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9585601&form=6&db=m Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. causal interaction,unassigned 3,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10484808&form=6&db=m Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. causal interaction,therapeutic application,unassigned 2,1,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10488719&form=6&db=m Phosphomannose isomerase deficiency as a cause of congenital hepatic fibrosis and protein-losing enteropathy. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10586187&form=6&db=m Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10963387&form=6&db=m Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10980531&form=6&db=m Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). causal interaction,ongoing research,unassigned 3,2,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12069534&form=6&db=m Clinical approach to inherited metabolic disorders in neonates: an overview. causal interaction,unassigned 3,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12434892&form=6&db=m Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19101627&form=6&db=m The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. causal interaction,therapeutic application,unassigned 4,4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22899857&form=6&db=m A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. unassigned - 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24508628&form=6&db=m Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption. causal interaction,therapeutic application,unassigned 4,1,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24569608&form=6&db=m Clinical utility gene card for: Phosphomannose isomerase deficiency. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24982104&form=6&db=m Successful liver transplantation and long-term follow-up in a patient with MPI-CDG. causal interaction,unassigned 4,0 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26430078&form=6&db=m A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies. unassigned - 5.3.1.8 mannose-6-phosphate isomerase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32963965&form=6&db=m Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy. causal interaction,unassigned 4,0 5.3.1.8 Metabolic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33098580&form=6&db=m Long term outcome of MPI-CDG patients on D-mannose therapy. causal interaction,unassigned 2,0 5.3.1.8 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4274344&form=6&db=m [Glycogen myopathy with a probable deficiency of phosphohexoisomerase. Preliminary report] causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=609205&form=6&db=m [Clinical evaluation of the sedimentation reaction to cancer, indices of uropepsinogen and phosphohexoisomerase activity in the blood serum of patients with stomach cancer] diagnostic usage,ongoing research,unassigned 4,1,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1291468&form=6&db=m Evaluation of Ehrlich's test as screening test for cancer. diagnostic usage,ongoing research,therapeutic application,unassigned 4,3,2,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2006007&form=6&db=m Glucosephosphate isomerase as a CSF marker for leptomeningeal metastasis. causal interaction,diagnostic usage,unassigned 4,4,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6450330&form=6&db=m Alterations in erythrocyte enzymes in cancer. causal interaction,diagnostic usage,unassigned 4,3,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17340808&form=6&db=m [Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia] causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33173340&form=6&db=m Mannose Impairs Lung Adenocarcinoma Growth and Enhances the Sensitivity of A549 Cells to Carboplatin. therapeutic application,unassigned 1,0 5.3.1.8 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34313879&form=6&db=m MPI-based bioinformatic analysis and co-inhibitory therapy with mannose for oral squamous cell carcinoma. therapeutic application,unassigned 1,0 5.3.1.8 Parasitic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27699809&form=6&db=m Complexes of a Zn-metalloenzyme binding site with hydroxamate-containing ligands. A case for detailed benchmarkings of polarizable molecular mechanics/dynamics potentials when the experimental binding structure is unknown. causal interaction,therapeutic application,unassigned 2,4,0 5.3.1.8 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4444250&form=6&db=m [Determination of phosphohexoisomerase activity in chronic pneumonia] diagnostic usage,ongoing research,unassigned 2,2,0 5.3.1.8 Protein-Losing Enteropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10488719&form=6&db=m Phosphomannose isomerase deficiency as a cause of congenital hepatic fibrosis and protein-losing enteropathy. causal interaction,unassigned 4,0 5.3.1.8 Protein-Losing Enteropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10586187&form=6&db=m Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. causal interaction,unassigned 4,0 5.3.1.8 Protein-Losing Enteropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10963387&form=6&db=m Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency. causal interaction,unassigned 4,0 5.3.1.8 Protein-Losing Enteropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21240668&form=6&db=m Seizures and stupor during intravenous mannose therapy in a patient with CDG syndrome type 1b (MPI-CDG). unassigned - 5.3.1.8 Protein-Losing Enteropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32905087&form=6&db=m Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia. causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Sarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1892247&form=6&db=m Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH). ongoing research,unassigned 2,0 5.3.1.8 Sinus Thrombosis, Intracranial http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32905087&form=6&db=m Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia. causal interaction,therapeutic application,unassigned 3,1,0 5.3.1.8 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31767777&form=6&db=m Sugar-Phosphate Metabolism Regulates Stationary-Phase Entry and Stalk Elongation in Caulobacter crescentus. therapeutic application,unassigned 1,0 5.3.1.8 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34533861&form=6&db=m Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 5.3.1.8 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=609205&form=6&db=m [Clinical evaluation of the sedimentation reaction to cancer, indices of uropepsinogen and phosphohexoisomerase activity in the blood serum of patients with stomach cancer] diagnostic usage,ongoing research,unassigned 4,1,0 5.3.1.8 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7023046&form=6&db=m [Effect of insulin on the activity of serum phosphohexoisomerase in gastric cancer] diagnostic usage,ongoing research,unassigned 2,4,0 5.3.1.8 Thrombocytopenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9821433&form=6&db=m Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,3,0 5.3.1.8 Thrombophilia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32905087&form=6&db=m Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia. causal interaction,therapeutic application,unassigned 3,1,0